AVBCC Value-Based Voices

The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.

AVBCC Value-Based Voices is a business podcast hosted by Rachael, with 14 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Rachael hosts AVBCC Value-Based Voices, a business show with 14 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #15

  From Patient to Person: Redefining Cancer Care at the AVBCC LA Regional Collaborative

  Sep 1, 202638 minS1

  In this episode of Value‑Based Voices, host Deirdre “Dee” Saulet, PhD, Chief Strategy Officer, Jasper Health, and AVBCC Southwest Regional Collaborative Co-Chair, sits down with two extraordinary guests, Kommah "Koko" McDowell, MS, a 21‑year survivor, nationally recognized advocate, and Chief Customer Officer at Tali Health, and Leon Cristobal, MPH, an eight‑year leukemia survivor, and Oncology Sales Consultant, Bayer. Recorded following the AVBCC Regional Collaborative in Los Angeles, this conversation explores what person‑centered care truly looks like in practice—and why the distinction between “patient” and “person” is more than semantics. Koko and Leon share candid reflections on being seen, heard, dismissed, supported, and ultimately cared for by the teams who walked alongside them. Together, they unpack the realities of ageism, cultural bias, caregiver strain, communication gaps, and the emotional weight of diagnosis. They also illuminate the frontline heroes—nurses, navigators, physicians, and access teams—whose humanity shapes the cancer experience. This episode is a call to action for every stakeholder across oncology to design solutions with humility, curiosity, and a commitment to treating people as whole beings. A powerful, deeply human conversation you won’t forget. Resources AVBCC Regional Collaboratives: avbcc.org/regional-collaboratives Association for Value‑Based Cancer Care (AVBCC): avbcc.org City of Hope: cityofhope.org Connect with the Speakers KoKo McDowell: https://www.linkedin.com/in/kommahmcdowell/ Leon Cristobal: https://www.linkedin.com/in/leon-cristobal/ Deirdre “Dee” Saulet: https://www.linkedin.com/in/deirdresaulet/ Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

  ListenShow Notes
• 

  AVBCC Value-Based Voices

  Red Tape: Real Consequences for Patients with Cancer

  Aug 25, 202642 min

  What happens when patients with cancer spend weeks navigating insurance requirements before receiving physician-prescribed care? In our latest episode of Value-Based Voices, Brian Reid , Principal of Reid Strategic and author of the Cost Curve newsletter, and Jayson Slotnik , JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sit down with Cancer Care' s Alexandra Zaleta , PhD, VP of Research & Insights, and Kim Czubaruk , JD, VP of Policy, to discuss findings from Cancer Care 's groundbreaking Red Tape Report . Based on responses from more than 1,200 people affected by cancer, the report sheds light on the very real impact of prior authorization, coverage interruptions, step therapy, and other utilization management practices on patients and families. Our conversation explores: • The clinical, financial, and emotional impact of treatment delays • Why patients with employer-sponsored coverage reported some of the greatest administrative burdens • The growing challenge of "time toxicity" for both patients and caregivers • Coverage disruptions during active treatment • Opportunities for employers, providers, policymakers, and advocates to work together on solutions One theme emerged clearly throughout the discussion: when access barriers delay care, the costs extend far beyond claims data. Patients, caregivers, providers, and employers all feel the impact. Resources: Cancer Care : https://www.cancercare.org/ The Red Tape Report: https://www.cancercare.org/redtape Connect with our Guests: Alexandra Zaletta, PhD: https://www.linkedin.com/in/alexandra-zaleta/ Kim Zubarak, JD: https://www.linkedin.com/in/kim-czubaruk-50532261/ Brian Reid: https://www.linkedin.com/in/brianbreid/ Jayson Slotnik, JD, MPH: https://www.linkedin.com/in/jayson-slotnik-3932305/ #ValueBasedCare #Oncology #CancerCare #HealthcarePolicy #PatientAccess #PriorAuthorization #CancerAdvocacy #HealthBenefits #ValueBasedVoices #CancerCareDelivery Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

  ListenShow Notes
• 

  Episode #13

  Part D Upheaval: Why the Cancer Community Needs to Pay Attention

  Aug 11, 202647 minS1

  In this episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sits down with Joel White, Partner and Head of Health Practice at Monument Advocacy, and a principal architect of Medicare Part D, to discuss one of the most consequential challenges facing cancer care today: the end of the Part D Premium Stabilization Demonstration. Bringing unmatched historical insight, policy fluency, and practical clarity to the conversation, Joel breaks down how we got here, how this decision will affect access to cancer therapies, and the real, actionable solutions that could stabilize the market and protect patients. Tune in to gain an understanding for this moment and the path forward! Resources & Links: Medicare Part D overview: https://www.medicare.gov/drug-coverage-part-d Medicare Extra Help / Low-Income Subsidy: https://www.ssa.gov/medicare/part-d-extra-help Connect with Our Guests: Connect with Joel White: / joel-white-6b8a953/ Connect with Jayson Slotnik: / jayson-slotnik-3932305 Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

  ListenShow Notes
• 

  Episode #12

  Can the U.S. Keep Its Edge? FDA Policy, China’s Momentum, and the Future of Innovation

  Aug 4, 202638 minS1

  In this follow up conversation, Jayson Slotnik, JD, MPH , Partner at Health Policy Strategies and AVBCC Board Members, and Steve Usdin , Senior Editor, Washington, BioCentury Publications, take a clear eyed look at the future of the FDA and the forces shaping biopharmaceutical innovation. Building on their earlier discussion of FDA history and political dynamics, Steve offers candid insights into how U.S. policy, global competition - particularly with China - and shifting regulatory priorities are influencing the life sciences ecosystem. He explores: - the implications of NIH funding erosion - restrictions on international collaboration - immigration challenges - the growing tension around drug pricing and intellectual property - practical realities companies and investors must navigate in coming months The episode also examines what the FDA can do to strengthen clinical trial efficiency, restore transparency, and rebuild confidence across industry and patient communities. Thoughtful, timely, and grounded in deep policy expertise, this conversation offers listeners a nuanced understanding of where the FDA is headed, and what that means for the future of oncology innovation. If you missed Part 1 of this conversation, catch it here . Resources & Links: BioCentury Publications Operation Trial Blazer Connect with Our Guests : Connect with Steve Usdin Connect with Jayson Slotnik Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

  ListenShow Notes
• 

  Episode #11

  The Future of the FDA: What Comes Next?

  Jul 28, 202626 minS1

  In this first of a 2-part series featuring Steve Usdin , Senior Editor, Washington, BioCentury Publications, host Jayson Slotnik, JD, MPH , Partner at Health Policy Strategies and AVBCC Board Member, leads a spirited conversation around developments at the FDA, the political influence shaping its decisions, and the outlook for the future. Key topics covered include: The state of morale among FDA career staff and the challenges in attracting new talent Eroding confidence levels within the investor community and implications for funding Political and ideological influence on FDA activities The debate over the upcoming FDA commissioner appointment and potential candidates The significance of recent initiatives like Operation Trial Blazer in restoring confidence Opportunities for optimism with FDA’s recent engagement with rare disease advocates and international collaboration efforts Resources & Links: BioCentury Publications Operation Trial Blazer Connect with Our Guests: Connect with Steve Usdin Connect with Jayson Slotnik Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

  ListenShow Notes

Recent guests on AVBCC Value-Based Voices. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.